IMMX
Immix BiopharmaBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
IMMX vs peer average
59/100
IMMX vs. peer average (B vs. C)
Grade spread
A 3 · B 2 · C 3 · D 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
NMRA is the first available peer comparator.
Loose small-cap clinical biotech peer useful mainly for event-driven trial-readout and financing-volatility context rather than indication match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMMX
Immix Biopharma
NMRA
Neumora Therapeutics
Grade
B
C
Momentum
89
98
Value
41
41
Sentiment
51
21
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs NMRA
IMMX / NMRA
Grade Position
In line
IMMX vs. peer average (B vs. C)
59/100
Momentum
89
NMRAValue
41
IMMXSentiment
51
IMMXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMMX
NMRA is the first peer returned for this comparison set.